The vaccine was licensed for another strain, and it is the one there is

On Saturday 19 September, in Bunia, which the Associated Press calls the epicentre of Congo's Ebola outbreak, vaccination of health workers began. By the AP's account the World Health Organization said last month that 70,000 doses of Ervebo had been approved for use in Congo, about 50,000 of them for front-line and health workers and 20,000 for a clinical trial, under a compassionate-use programme, because Ervebo is licensed against disease caused by the Zaire strain, and the Bundibugyo virus ca ...